Top Trials and Data at ACC.24, with Deepak Bhatt, MD, MPH, MBA

Ahead of the American College of Cardiology 2024 (ACC.24) Annual Scientific Session, the HCPLive Cardiology team sat down with Deepak Bhatt, MD, MPH, MBA, the Dr. Valentin Fuster Professor of Cardiovascular Medicine and director of Mount Sinai Heart, to learn what trials he was most excited for at the upcoming meeting. Now, with ACC.24 completed, the team caught up with Bhatt for his perspective on the most important trials presented at the meeting and how they influence practice or research in cardiology.
Highlights
0:10 EMPACT-MI
2:48 REDUCE-AMI
4:58 ULTIMATE DAPT
9:11 DanGer Shock
12:49 AEGIS-II
Link to full article: www.hcplive.co...
#cardiology #acc #heart

[@adithyavikram7]

Respected professor when usually you start Sglt2 inhibitors in your practice in a patient with acute mi, like immediately or 24 hours or after 72 hours or during discharge, when you want to prefer the Sglt2 inhibitor professor, thank you in anticipation.